CeraCare products are also being marketed for pets and other animals. The FDA has not approved CBD for any use in animals and the concerns regarding diabetes glucose products with unproven medical claims and of unknown quality equally apply to CeraCare Diabetes Pills products marketed for animals. The FDA recommends pet owners talk with their veterinarians about appropriate treatment options for their pets. Misleading, unproven, or false claims associated with CBD products may lead consumers to put off getting important medical care, such as proper diagnosis, treatment, and supportive care.